BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36555747)

  • 21. Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses.
    Bertelli E; Palombella A; Sessa F; Baldi I; Morelli N; Verna S; Greco I; Morselli S; Pili A; Sebastianelli A; Berni A; Nicoletti R; Minervini A; Carini M; Gacci M; Miele V; Agostini S; Serni S; Campi R
    World J Urol; 2021 Aug; 39(8):2853-2860. PubMed ID: 33495864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma.
    Cairns P
    Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis and prognosis of small renal masses: association with collateral vessels detected using contrast-enhanced computed tomography.
    Yanagi M; Kiriyama T; Akatsuka J; Endo Y; Takeda H; Katsu A; Honda Y; Suzuki K; Nishikawa Y; Ikuma S; Mikami H; Toyama Y; Kimura G; Kondo Y
    BMC Cancer; 2022 Aug; 22(1):856. PubMed ID: 35932010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.
    Daugherty M; Sedaghatpour D; Shapiro O; Vourganti S; Kutikov A; Bratslavsky G
    Urol Oncol; 2017 Apr; 35(4):153.e15-153.e20. PubMed ID: 28202224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses?
    Phé V; Yates DR; Renard-Penna R; Cussenot O; Rouprêt M
    BJU Int; 2012 Mar; 109(6):867-72. PubMed ID: 21895938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
    Müller M; Goessl C; Krause H; Miller K
    Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
    Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
    J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.
    Morris MR; Ricketts CJ; Gentle D; McRonald F; Carli N; Khalili H; Brown M; Kishida T; Yao M; Banks RE; Clarke N; Latif F; Maher ER
    Oncogene; 2011 Mar; 30(12):1390-401. PubMed ID: 21132003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
    J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive urine markers for the differentiation between RCCs and oncocytoma.
    von Brandenstein M; Herden J; Köditz B; Huerta M; Nestler T; Heidenreich A; Fries JWU
    J Clin Lab Anal; 2021 May; 35(5):e23762. PubMed ID: 33960011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma.
    Andersson-Evelönn E; Vidman L; Källberg D; Landfors M; Liu X; Ljungberg B; Hultdin M; Rydén P; Degerman S
    J Transl Med; 2020 Nov; 18(1):435. PubMed ID: 33187526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review on the Management of Small Renal Masses: Active Surveillance Versus Surgery.
    Marra G; Oderda M; Allasia M; Munegato S; Joniau S; Gontero P
    Anticancer Agents Med Chem; 2018; 18(7):940-950. PubMed ID: 29141564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression Levels of PIWI-interacting RNA, piR-823, Are Deregulated in Tumor Tissue, Blood Serum and Urine of Patients with Renal Cell Carcinoma.
    Iliev R; Fedorko M; Machackova T; Mlcochova H; Svoboda M; Pacik D; Dolezel J; Stanik M; Slaby O
    Anticancer Res; 2016 Dec; 36(12):6419-6423. PubMed ID: 27919963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
    Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
    Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
    Gonzalgo ML; Yegnasubramanian S; Yan G; Rogers CG; Nicol TL; Nelson WG; Pavlovich CP
    Clin Cancer Res; 2004 Nov; 10(21):7276-83. PubMed ID: 15534102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
    He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
    BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Methylation of the 1p36 Tumor Suppressor Gene RIZ1 in Renal Cell Carcinoma.
    Ge P; Yu X; Wang ZC; Lin J
    Asian Pac J Cancer Prev; 2015; 16(9):4071-5. PubMed ID: 25987089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma.
    Evelönn EA; Landfors M; Haider Z; Köhn L; Ljungberg B; Roos G; Degerman S
    BMC Cancer; 2019 Jan; 19(1):65. PubMed ID: 30642274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.